Objective:To investigate the inflammatory and antioxidant activities of ethanolic extract of aerial part of Vernonia patula (Dryand.) Merr (EAV).
Methods:The anti-inflammatory activity of EAV was studied using carrageenan and histamine-induced rat paw edema test at different doses (100, 200 and 400 mg/kg body weight). DPPH free radical scavenging, nitric oxide scavenging, reducing power and Fe2+ion chelating ability were used for determining antioxidant activities.
Results: The EAV, at the dose of 400 mg/kg, showed a significant anti-inflammatory activity (P<0.01) both in the carrageenan and histamine-induced oedema test models in rats, showing 62.86%and 64.42%reduction in the paw volume comparable to that produced by the standard drug indomethacin (67.26%and 66.01%) at 5 h respectively. In DPPH free radical scavenging test, IC50 value for EAV was found fairly significant 36.59 μg/mL when compared to the IC50 value of the reference standards ascorbic acid 8.97 μg/mL. The IC50 values of the extract and ascorbic acid were 47.72 and 12.39 μg/mL, respectively in nitric oxide scavenging assay. The IC50 value of the EAV (33.59 μg/mL) as percentage of Fe2+ion chelating ability was also found significant compared to that of EDTA (9.16 μg/mL). The maximum absorbance for reducing power assay was found to be 1.928 at 100 μg/mL when compared to 2.449 for standard ascorbic acid. The total phenolic content was 198.81 mg/g of gallic acid equivalent. Acute toxicity test showed that the plant might be safe for pharmacological uses up to a dose level of 3 200 mg/kg of body weight in rats.
Conclusions: Therefore, the obtained results suggest the acute anti-inflammatory and antioxidant activities of the EAV and thus provide the scientific basis for the traditional uses of this plant part as a remedy for inflammations.

The harshness of legionellosis differs from mild Pontiac fever to potentially fatal Legionnaire's disease. The increasing development of drug resistance against legionellosis has led to explore new novel drug targets. It has been found that phosphoglucosamine mutase, phosphomannomutase, and phosphoglyceromutase enzymes can be used as the most probable therapeutic drug targets through extensive data mining. Phosphoglucosamine mutase is involved in amino sugar and nucleotide sugar metabolism. The purpose of this study was to predict the potential target of that specific drug. For this, the 3D structure of phosphoglucosamine mutase of Legionella pneumophila (strain Paris) was determined by means of homology modeling through Phyre2 and refined by ModRefiner. Then, the designed model was evaluated with a structure validation program, for instance, PROCHECK, ERRAT, Verify3D, and QMEAN, for further structural analysis. Secondary structural features were determined through self-optimized prediction method with alignment (SOPMA) and interacting networks by STRING. Consequently, we performed molecular docking studies. The analytical result of PROCHECK showed that 95.0% of the residues are in the most favored region, 4.50% are in the additional allowed region and 0.50% are in the generously allowed region of the Ramachandran plot. Verify3D graph value indicates a score of 0.71 and 89.791, 1.11 for ERRAT and QMEAN respectively. Arg419, Thr414, Ser412, and Thr9 were found to dock the substrate for the most favorable binding of S-mercaptocysteine. However, these findings from this current study will pave the way for further extensive investigation of this enzyme in wet lab experiments and in that way assist drug design against legionellosis.
Computer Simulation* ; Data Mining ; Drug Delivery Systems ; Drug Design ; Drug Resistance ; Fever ; Legionella pneumophila* ; Legionellosis* ; Legionnaires' Disease ; Metabolism ; Phosphoglycerate Mutase

Aims: The combination of knowledge, attitudes and practices is an important psycho-behavioural mechanism in the disease-management strategies of HIV patients. This study reviews the global evidence of knowledge, attitudes and practices (KAP) of HIV patients. Design: Systematic review. Data sources: Four databases- Pubmed, Scopus, Science Direct and Web of Science (WOS) were searched from January 10 to April 25, 2021. Methods: Databases were searched for the predefined keywords of “knowledge”, “attitudes”, “practices”, “people living with HIV/AIDS” and “HIV/AIDS”. The inclusion criteria were limited to time range, language and study types and nature. PRISMA was followed and JBI quality assessment tools for cross-sectional and qualitative studies were used. Results: A total of 18 papers have been selected for the extraction of 1964 articles. The KAP were assessed related to nutrition, infant feeding, disclosure of HIV/AIDS, WASH (or hygiene), oral health, cancer-related domains with HIV/AIDS and HA(ART). Relevant dimensional KAP were incorporated with the basic items about HIV/AIDS. Overall, a mixed level of knowledge, discriminatory attitudes and malpractices were observed throughout the study. Socio-economic, counselling, support and dimensions related factors were identified as associated risk factors. Conclusion: Variation in assessing KAP is a critical problem and unique, outcome-based KAP assessment tools integrated with qualitative assessments were suggested to examine the interrelationship of the KAP components and outcomes.

Thrombotic microangiopathy (TMA) is characterized by systemic microvascular thrombosis, target organ injury, anemia and thrombocytopenia. Thrombotic thrombocytopenic purpura, atypical hemolytic uremic syndrome and Shiga toxin E-coli-related hemolytic uremic syndrome are the three common forms of TMAs. Traditionally, TMA is encountered during pregnancy/postpartum period, malignant hypertension, systemic infections, malignancies, autoimmune disorders, etc. Recently, the patients presenting with trauma have been reported to suffer from TMA. TMA carries a high morbidity and mortality, and demands a prompt recognition and early intervention to limit the target organ injury. Because trauma surgeons are the first line of defense for patients presenting with trauma, the prompt recognition of TMA for these experts is critically important. Early treatment of post-traumatic TMA can help improve the patient outcomes, if the diagnosis is made early. The treatment of TMA is also different from acute blood loss anemia namely in that plasmapheresis is recommended rather than platelet transfusion. This article familiarizes trauma surgeons with TMA encountered in the context of trauma. Besides, it provides a simplified approach to establishing the diagnosis of TMA. Because trauma patients can require multiple transfusions, the development of disseminated intravascular coagulation must be considered. Therefore, the article also provides different features of disseminated intravascular coagulation and TMA. Finally, the article suggests practical points that can be readily applied to the management of these patients.